Literature DB >> 22251894

Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2.

Renée Vancraenenbroeck1, Evy Lobbestael, Stephen D Weeks, Sergei V Strelkov, Veerle Baekelandt, Jean-Marc Taymans, Marc De Maeyer.   

Abstract

Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of familial Parkinson's disease. Much research effort has been directed towards the catalytic core region of LRRK2 composed of GTPase (ROC, Ras of complex proteins) and kinase domains and a connecting COR (C-terminus of ROC) domain. In contrast, the precise functions of the protein-protein interaction domains, such as the leucine-rich repeat (LRR) domain, are not known. In the present study, we modeled the LRRK2 LRR domain (LRR(LRRK2)) using a template assembly approach, revealing the presence of 14 LRRs. Next, we focused on the expression and purification of LRR(LRRK2) in Escherichia coli. Buffer optimization revealed that the protein requires the presence of a zwitterionic detergent, namely Empigen BB, during solubilization and the subsequent purification and characterization steps. This indicates that the detergent captures the hydrophobic surface patches of LRR(LRRK2) thereby suppressing its aggregation. Circular dichroism (CD) spectroscopy measured 18% α-helices and 21% β-sheets, consistent with predictions from the homology model. Size exclusion chromatography (SEC) and dynamic light scattering measurements showed the presence of a single species, with a Stokes radius corresponding to the model dimensions of a protein monomer. Furthermore, no obvious LRR(LRRK2) multimerization was detected via cross-linking studies. Finally, the LRR(LRRK2) clinical mutations did not influence LRR(LRRK2) secondary, tertiary or quaternary structure as determined via SEC and CD spectroscopy. We therefore conclude that these mutations are likely to affect putative LRR(LRRK2) inter- and intramolecular interactions. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22251894     DOI: 10.1016/j.bbapap.2011.12.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Down-regulation of LRRK2 in control and DAT transfected HEK cells increases manganese-induced oxidative stress and cell toxicity.

Authors:  Jerome A Roth; Michelle Eichhorn
Journal:  Neurotoxicology       Date:  2013-04-27       Impact factor: 4.294

2.  Structural and functional in silico analysis of LRRK2 missense substitutions.

Authors:  Fernando Cardona; Marta Tormos-Pérez; Jordi Pérez-Tur
Journal:  Mol Biol Rep       Date:  2014-02-02       Impact factor: 2.316

3.  Direct evidence for a new mode of plant defense against insects via a novel polygalacturonase-inhibiting protein expression strategy.

Authors:  Wiebke Haeger; Jana Henning; David G Heckel; Yannick Pauchet; Roy Kirsch
Journal:  J Biol Chem       Date:  2020-07-01       Impact factor: 5.157

4.  The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling.

Authors:  Nicolas Dzamko; Francisco Inesta-Vaquera; Jiazhen Zhang; Chengsong Xie; Huaibin Cai; Simon Arthur; Li Tan; Hwanguen Choi; Nathanael Gray; Philip Cohen; Patrick Pedrioli; Kristopher Clark; Dario R Alessi
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

Review 5.  Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation.

Authors:  Bernd K Gilsbach; Arjan Kortholt
Journal:  Front Mol Neurosci       Date:  2014-05-05       Impact factor: 5.639

Review 6.  Phosphatases of α-synuclein, LRRK2, and tau: important players in the phosphorylation-dependent pathology of Parkinsonism.

Authors:  Jean-Marc Taymans; Veerle Baekelandt
Journal:  Front Genet       Date:  2014-11-07       Impact factor: 4.599

7.  Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes.

Authors:  Kushal Sejwal; Mohamed Chami; Hervé Rémigy; Renée Vancraenenbroeck; William Sibran; Rosmarie Sütterlin; Paul Baumgartner; Robert McLeod; Marie-Christine Chartier-Harlin; Veerle Baekelandt; Henning Stahlberg; Jean-Marc Taymans
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

Review 8.  Physiological and pathological functions of LRRK2: implications from substrate proteins.

Authors:  Miho Araki; Genta Ito; Taisuke Tomita
Journal:  Neuronal Signal       Date:  2018-10-10

9.  Lack of correlation between the kinase activity of LRRK2 harboring kinase-modifying mutations and its phosphorylation at Ser910, 935, and Ser955.

Authors:  Genta Ito; Tetta Fujimoto; Shogo Kamikawaji; Tomoki Kuwahara; Takeshi Iwatsubo
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

10.  Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways.

Authors:  Lauran Reyniers; Maria Grazia Del Giudice; Laura Civiero; Elisa Belluzzi; Evy Lobbestael; Alexandra Beilina; Giorgio Arrigoni; Rita Derua; Etienne Waelkens; Yan Li; Claudia Crosio; Ciro Iaccarino; Mark R Cookson; Veerle Baekelandt; Elisa Greggio; Jean-Marc Taymans
Journal:  J Neurochem       Date:  2014-07-14       Impact factor: 5.372

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.